Community-Associated Methicillin-Resistant Staphylococcus aureus: New Bug,Old Drugs

Baba T , Takeuchi F , Kuroda M. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359:1819–27.

Francis JS , Doherty MC , Lopatin U. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:400–7.

Archer GL . Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998;26:1179–81.

Skinner D , Keefer CS . Significance of bacteremia caused by Staphylococcus aureus. Arch Intern Med 1941; 68: 851–75.

Chambers HF . The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178–82.

Palavencino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med 2004;24:403–18.

Barrett FF , McGehee RF , Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441–8.

Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 1999; 48: 707–10.

Begier EM , Frenette K , Barrett BL . A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf bums. Clin Infect Dis 2004;39:1446–53.

Lindenmayer JM , Schoenfield S , O'grady R , Carney JK . Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998;158:895–9.

Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 793–5.

Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 992–6.

Groom AV , Wolsey DH , Naimi TS . Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201–5.

Fergie JE , Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 2001;20:860–3.

Moreillon P , Que Y , Glauser MP . Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL , Bennett JE , Dolin R , eds. Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier, 2004;2321–51.

Daum RS , Ito T , Hiramatsu K. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002;186:1344–7.

Eady EA , Cove JS . Staphylococcal resistance revisited: community-acquired methicillin-resistant Staphylococcus aureus—an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003;16:103–24.

Charlebois ED , Perdreau-Remington F , Kreisworth B. Origins of community strains of methicillin resistant Staphylococcus aureus. Clin Infect Dis 2004; 39: 47–54.

Fridkin SK , Hagerman JC , Morrison M , Sanza LT , Como-Sabetti K , Jemigan JA . Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436–44.

Naimi TS , LeDell KH , Como-Sabetti K. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976–84.

Almer LS , Shortridge VD , Nilius AM . Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2002; 43: 225–32.

Mongkolrattanothai K , Boyle S , Kahana MD , Daum RS . Severe Staphylococcal aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003;37:1050–8.

McDougal LK , Steward CD , Killgore GE , Chaitram JM , McAllister SK , Tenover FC . Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113–20.

Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 88.

Diep BA , Gill SR , Chang RF . Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006; 367: 705–6.

Okuma K , Iwakawa K , Turnidge JD . Dissemination of new methicillin-reisistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002;40:4289–94.

Ma XX , Ito T , Tiensasitorn C. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002;46:1147–52.

Hiramatsu K , Okuma K , Ma X , Yamamoto M , Hori S , Kapi M. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Curr Opin Infect Dis 2002;15:407–13.

Ito T , Ma XX , Takeuchi F , Keiko O , Yuzaawa H , Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48: 2637–51.

Tacconelli E , Venkataraman L , DeGirolami PC , D'agata EMC . Methi-cillin-resistant Staphylococcus aureus bacteremia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 2004;53:474–9.

Rybak MJ , La Plante K. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005;25:74–85.

Panton PN , Valentine FCO . Staphylococcal toxin. Lancet 1932;1:506–8.

Lina G , Peimont Y , Godall-Gamot F. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128–32.

Gillet Y , Issartel B , Venhems P. Association between Staphylococcus aureus strains carrying genes for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002;359:753–9.

Boubaker K , Diebold P , Blanc DS . Panton-Valentine leukocidin and staphylococcal skin infections in schoolchildren. Emerg Infect Dis 2004;10:121–4.

Vandenesch F , Naimi T , Enright MC . Community-acquired methicillin-resistant Staphylococcus aureus infections carrying Panton-Valentine leukocidin: worldwide emergence. Emerg Infect Dis 2003;9:978–84.

DuFour P , Gillet Y , Bes M. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819–24.

Diep BA , Sensabaugh GE , Somboona NS , Carleton HA , Pendreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton–Valentine leukocidin. J Clin Microbiol 2004;42:2080–4.

Bagget HC , Hennessy TW , Rudolph K. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton–Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189:1565–73.

Ellis M , Hospenthal D , Dooley D , Gray P , Murray CK . Natural history of community-acquired methicillin-resistant Staphylococcal aureus infection in soldiers. Clin Infect Dis 2004;39:971–9.

Markowitz N , Quinn EL , Saravolatz LD . Trimethoprim-sulfamethoxazole compared with vancomycin for treatment of Staphylococcal aureus infections. Ann Intern Med 1992;117:390–8.

Reese RE , Betts RF . Clindamycin. In: Betts RF , Chapman SW , Penn RL , eds. Reese and Betts’ a practical approach to infectious diseases. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2003;1077–80.

Package insert. Vibramycin (doxycycline). New York: Pfizer, September 2003.

Package insert. Minocin (minocycline). Philadelphia: Wyeth Pharmaceuticals, October 2005.

Package insert. Levaquin (levofloxacin). Raritan, NJ: Ortho-McNeil Pharmaceutical, August 2005.

Package insert. Tequin (gatifloxacin). Princeton, NJ: Bristol-Myers Squibb September 2005.

Package insert. Avelox (moxifloxacin). West Haven, CT: Bayer Health-Care, July 2005.

Package insert. Zyvox (linezolid). New York: Pfizer, November 2005.

Adra M , Lawrence KR . Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 2004;38:338–41. Epub 30 Dec 2003. DOI 10.1345/aph.lD156

Elwell LP , Wilson HR , Knick VB , Keith BR . In vitro and in vivo efficacy of the combination of trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1986; 29: 1092–4.

Hedstrom SA . Clindamycin as an anti-staphylococcal agent—indications and limitations. Scand J Infect Dis Suppl 1984;43:62–6.

Frank AL , Marcinak JF , Mangat PD , Schrekenberger PC . Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999;18:993–1000.

Lewis JS , Jorgensen JH . Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005;40:280–5.

Performance standards for antimicrobial susceptibility testing: 14th informational supplement. M100-S14. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.

Qadri SMH , Halim M , Ueno Y , Saldin H. Susceptibility of methicillin-resistant Staphylococcus aureus to minocycline and other antimicrobials. Chemotherapy 1994;40:26–9.

Lewis SA , Altemeier WA . Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use. Chemotherapy 1976;22:319–23.

Minuth JN , Holmes TN , Musher DM . Activity of tetracycline, doxycycline and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother 1974;6:411–4.

Yuk JH , Dignani MC , Harris RL , Bradshaw MW , Williams TW . Minocycline as an alternative antistaphylococcal agent. Rev Infect Dis 1991; 13:1023–4.

Yourassowsky E , van der Linden MP , Lismont MJ , Crokaert F. Combination of minocycline and rifampicin against methicillin-resistant and gentamicin-resistant Staphylococcus aureus. J Clin Pathol 1981; 34: 559–63.

Segretti J , Gvazdinskas LC , Trenholme GM . In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis 1989;12:253–5.

Clumeck N , Marcelis L , Amiri-Iamraski MH , Gordts B. Treatment of severe staphylococcal infections with a rifampicin–minocycline association. J Antimicrob Chemother 1984;13(suppl C): 17–22.

Ruhe JJ , Monson T , Bradsher RW , Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005;40:1429–34.

Schaefler S. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol 1989;27:335–6.

Kaatz GW , Seo SM , Ruble CA . Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J Infect Dis 1991; 163: 1080–6.

Blumberg HM , Rimland D , Carroll DJ , Terry P , Wachsmuth IK . Emergence of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991; 163: 1279–85.

Peterson LR , Quick JN , Jensen B. Emergence of ciprofloxacin resistance to nosocomial methicillin-resistant Staphylococcus aureus isolates. Arch Intern Med 1990;50:2151–5.

Presterl E , Mueller-Uri P , Grisold A , Georgopoulos A , Graninger W. Ciprofloxacin- and methicillin-resistant Staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid. Eur J Clin Microbiol Infect Dis 2001;20:486–9.

Stein GE , Schooley S , Kaatz GW . Serum bactericidal activity of the methoxyfluoroquinolones gatifloxacin and moxifloxacin against clinical isolates of Staphylococcus species: are the susceptibility breakpoints too high? Clin Infect Dis 2003;37:1392–5.

National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. Wayne, PA: NCCLS, 2005.

Jones ME , Boenik NM , Verhoef J , Kohrer K , Schmitz F. Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment. J Antimicrob Chemother 2000;45:353–6.

Shopsin B , Zhao X , Kreisworth BN , Tillotson GS , Drlica K. Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus? Int J Antimicrob Agents 2004;24:32–4.

Weber SG , Gold HS , Hooper DC , Karchmer AW , Carmell Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2002;9:1415–22.

Stevens DL , Herr D , Lampiris H. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34:1481–90.

Weigelt J , Itani K , Stevens D , Lau W , Dryden M , Knirsch C . for the Linezolid CSSTI Study Group. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005;49:2260–6.

Tsiodras S , Gold HS , Sakoulas G. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358: 207–8.

Frippiat F , Bergiers C , Michel C , Dujardin J , Derue G. Severe bilateral optic neuritis associated with prolonged linezolid therapy. J Antimicrob Chemother 2004;53:1114–5.

Birmingham MC , Rayner CR , Meagher AK , Flavin SM , Batts DH , Schentag JJ . Linezolid for the treatment of multi-drug resistant, gram-positive infections: experiences from a compassionate use program. Clin Infect Dis 2003;36:159–68.

Package insert. Synercid (quinupristin/dalfopristin). Bristol, TN: Monarch Pharmaceuticals, July 2003.

Package insert. Cubicin (daptomycin). Lexington, MA: Cubist Pharmaceuticals, September 2003.

Package insert, Tygacil (tigeocycline). Philadelphia: Wyeth Pharmaceuticals, June 2005.

Perdreau-Remington F , Carleton HA , Etrorma J , Diep BA , Sensabaugh GF . Alarming prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in hospitalized patients (abstract K-1859-a). Presented at: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October 30-November 2, 2004.

King MD , Humphrey BJ , Wang YF . Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006;144:309–17.

Seybold U , Kourbatova EV , Johnson JG . Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647–56.

Hidron AI , Kaurbatova EV , Halvosa JS . Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005;41:159–66.